戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ratoire d'Excellence Integrative "Biology of Emerging Infectious Diseases".
2 ce Centers for Biodefense and Emerging or Re-Emerging Infectious Diseases'.
3 nt recent instance of spatial invasion by an emerging infectious disease.
4 milar to smallpox and is considered to be an emerging infectious disease.
5 respiratory syndrome (SARS) is a significant emerging infectious disease.
6  accelerated the understanding of this newly emerging infectious disease.
7 ssential for preventing and/or treating this emerging infectious disease.
8 s to a treatment is needed in response to an emerging infectious disease.
9 th strategy when confronted with a dangerous emerging infectious disease.
10 veys are conducted in the context of a newly emerging infectious disease.
11 short- and long-term protection against this emerging infectious disease.
12 of potential pathogens is crucial to control emerging infectious disease.
13 rus transmission is critical to anticipating emerging infectious diseases.
14 could provide an important novel therapy for emerging infectious diseases.
15 ent of plant-derived mAbs as therapy against emerging infectious diseases.
16  that can elicit protective immunity against emerging infectious diseases.
17 ategies against a variety of established and emerging infectious diseases.
18  just two of the most widely reported recent emerging infectious diseases.
19           Asia remains vulnerable to new and emerging infectious diseases.
20 ss to respond effectively to emerging and re-emerging infectious diseases.
21 s wildlife is crucial for risk assessment of emerging infectious diseases.
22  advancement of immunotherapeutics targeting emerging infectious diseases.
23 tial medications against the emerging and re-emerging infectious diseases.
24 thogen interactions and changing the risk of emerging infectious diseases.
25 r designing appropriate control measures for emerging infectious diseases.
26 fective strategies to mitigate the impact of emerging infectious diseases.
27  clinical implementation is critical such as emerging infectious diseases.
28 cy and rapid deployment capability to target emerging infectious diseases.
29 improved or new vaccines against existing or emerging infectious diseases.
30 are necessary to obtain robust forecasts for emerging infectious diseases.
31 -US Collaborative Program on Emerging and Re-emerging Infectious Diseases.
32 d and scavenging animals, creates a risk for emerging infectious diseases.
33 ce knowledge to prevent the spread of future emerging infectious diseases.
34 pid development of screening tools for novel emerging infectious diseases.
35 psy post-mortem in investigating endemic and emerging infectious diseases.
36  only pandemic preparedness but also against emerging infectious diseases.
37 al to understanding the risks and control of emerging infectious diseases.
38 ation and aid in the control of zoonotic and emerging infectious diseases.
39 erves as a paradigm for preparing for future emerging infectious diseases.
40 c health issue, especially with outbreaks of emerging infectious diseases.
41 e, rapid diagnosis and real-time tracking of emerging infectious diseases.
42 rch and development blueprint initiative for emerging infectious diseases.
43  tool for timely vaccine development against emerging infectious diseases.
44 patients with EVD and other high-consequence emerging infectious diseases.
45 , and equipment to rapidly identify rare and emerging infectious diseases.
46 es are a significant class of agents causing emerging infectious diseases.
47 rating or even preventing the spread of such emerging infectious diseases.
48 modeling pathogen-host interactions in other emerging infectious diseases.
49 n the ecological dynamics of established and emerging infectious diseases.
50  can be extended to other taxa threatened by emerging infectious diseases.
51   Wildlife is a global source of endemic and emerging infectious diseases.
52 are often the first available therapy for an emerging infectious disease, a stopgap treatment while n
53                         It is regarded as an emerging infectious disease affecting diverse amphibian
54                         Ophidiomycosis is an emerging infectious disease affecting wild snakes in the
55 nfection, has recently been identified as an emerging infectious disease affecting wild tit species i
56 ng the failure of effective immunity to this emerging infectious disease agent.
57 ends to understanding the spread of novel or emerging infectious disease, an alternative approach to
58 n to the far-reaching social implications of emerging infectious diseases, an issue with historical p
59 ealth concerns about the dissemination of an emerging infectious disease and highlights the need for
60  to test whether chronic bee paralysis is an emerging infectious disease and investigate the spatiote
61 hese methodologies is essential for tackling emerging infectious diseases and advancing therapeutic d
62 also potential for climate-driven impacts on emerging infectious diseases and antimicrobial resistanc
63                                              Emerging infectious diseases and biological invasions po
64  routine specimen screening surveillance for emerging infectious diseases and of joint integration of
65 c strategies to identify etiologic agents of emerging infectious diseases and once again demonstrates
66 to understand host responses and immunity to emerging infectious diseases and potential bioterrorism
67 treatment option for EBOV disease.IMPORTANCE Emerging infectious diseases are a major public health c
68                             More than 70% of emerging infectious diseases are acquired from animals,
69                                              Emerging infectious diseases are an important public hea
70 e reasons why southeast Asia is at risk from emerging infectious diseases are complex.
71        The regional challenges in control of emerging infectious diseases are formidable and range fr
72                                              Emerging infectious diseases are of major concern to ani
73        Mass mortality events associated with emerging infectious diseases are often associated with h
74                                              Emerging infectious diseases are reducing biodiversity o
75                                              Emerging infectious diseases are responsible for decline
76                Among the etiologic agents of emerging infectious diseases are several bacterial organ
77                        The majority of human emerging infectious diseases are zoonotic, with viruses
78 ic, that are rapidly scalable in response to emerging infectious diseases, are essential for both the
79 vere acute respiratory syndrome (SARS) is an emerging infectious disease associated with a high rate
80 ogenies are most often found in the field of emerging infectious diseases, but will become increasing
81 rium ulcerans, was identified as a neglected emerging infectious disease by WHO in 1998.
82                                              Emerging infectious diseases can have devastating effect
83    Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel coronaviru
84 s human risk of exposure to ehrlichiosis, an emerging infectious disease caused by bacterial pathogen
85           Human monocytic ehrlichiosis is an emerging infectious disease caused by Ehrlichia chaffeen
86 ROUNDCoronavirus disease 19 (COVID-19) is an emerging infectious disease caused by SARS-CoV-2.
87 rus disease 2019 (COVID-19) is defined as an emerging infectious disease caused by severe acute respi
88               Amphibian chytridiomycosis, an emerging infectious disease caused by the fungus Batrach
89                            Melioidosis is an emerging infectious disease caused by the intracellular
90                              Emerging and re-emerging infectious diseases caused by RNA viruses pose
91                                           An emerging infectious disease, chytridiomycosis, caused by
92 nificant threat to amphibians is a virulent, emerging infectious disease, chytridiomycosis, which app
93                              Emerging and re-emerging infectious diseases continue to pose a severe t
94                                              Emerging infectious diseases continue to pose a signific
95 arge-scale population declines globally, and emerging infectious diseases contribute heavily to these
96 a paradigm shift in our understanding of how emerging infectious diseases contribute to global patter
97          The COVID-19 pandemic has shown how emerging infectious diseases could quickly affect the gl
98  and systemic diseases, and preparedness for emerging infectious diseases.Database URL:
99 to investigate and control outbreaks, detect emerging infectious diseases, develop vaccines, and comb
100 bial cell-free DNA (mcfDNA) sequencing is an emerging infectious disease diagnostic tool which enable
101 diseases in Hong Kong which is a hotspot for emerging infectious diseases due to its high population
102  leucopus as a model organism for studies of emerging infectious diseases, ecology, and in other disc
103          Here we update a global database of emerging infectious disease (EID) events, create a novel
104 rstanding of the current and ongoing risk of emerging infectious disease (EID) transmission between m
105       There is an increasing global trend of emerging infectious diseases (EIDs) affecting a wide ran
106                                              Emerging infectious diseases (EIDs) are a significant bu
107                                              Emerging Infectious Diseases (EIDs) are recognised as gl
108                 The approach used so far for emerging infectious diseases (EIDs) does not work from t
109                      Microsporidia may cause emerging infectious diseases (EIDs) in bumblebees.
110                                         Most emerging infectious diseases (EIDs) in humans have arise
111              A central challenge to studying emerging infectious diseases (EIDs) is a landscape dilem
112                                              Emerging infectious diseases (EIDs) of free-living wild
113                                              Emerging infectious diseases (EIDs) of plants continue t
114                                              Emerging infectious diseases (EIDs) pose a risk to human
115                                              Emerging infectious diseases (EIDs) pose a significant t
116                                              Emerging infectious diseases (EIDs) threaten the health
117                         In the management of emerging infectious disease epidemics, precise and accur
118                              Emerging and re-emerging infectious diseases, especially those caused by
119                 Labex Integrative Biology of Emerging Infectious Diseases, EU 7th framework program P
120 ted within 27 y to reduce the annual rise of emerging infectious disease events by 50% at an estimate
121                     The increasing number of emerging infectious disease events that have spread inte
122 a fungus causing one of the most devastating emerging infectious disease ever recorded among vertebra
123 affeensis is a life-threatening, tick-borne, emerging infectious disease for which no satisfactory an
124                            Melioidosis is an emerging infectious disease for which there are currentl
125 veillance plays a crucial role in preventing emerging infectious diseases from becoming epidemic.
126             Developing prediction models for emerging infectious diseases from relatively small numbe
127 s exhibited lower average growth rates, this emerging infectious disease has the potential to reduce
128                                              Emerging infectious diseases have caused many species de
129                                              Emerging infectious diseases have exacted heavy public h
130             Recent outbreaks of animal-borne emerging infectious diseases have likely been precipitat
131                                              Emerging infectious diseases have resulted in severe pop
132                                              Emerging infectious diseases have risen to prominence du
133 cing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing
134 terium that invades neutrophils to cause the emerging infectious disease human granulocytic anaplasmo
135 s haplotype in Canada, this appears to be an emerging infectious disease in North America.
136 out intensive treatment and is a significant emerging infectious disease in Southeast Asia.
137        Human granulocytic ehrlichiosis is an emerging infectious disease in the United States and Eur
138 s disease is endemic in Latin America and an emerging infectious disease in the United States.
139       Our findings show Paridae pox to be an emerging infectious disease in wild birds in Great Brita
140 ak, as well as inevitable outbreaks of other emerging infectious diseases in China's Pearl River Delt
141                                 About 60% of emerging infectious diseases in humans are of zoonotic o
142                                 Up to 75% of emerging infectious diseases in humans today are the res
143 edict and mitigate the impact of endemic and emerging infectious diseases in wild populations.
144  and the public health impact resulting from emerging infectious diseases including the ongoing COVID
145 ats are a major reservoir of emerging and re-emerging infectious diseases, including severe acute res
146              Southeast Asia is a hotspot for emerging infectious diseases, including those with pande
147                                              Emerging infectious diseases increasingly threaten many
148        The development of vaccines to tackle emerging infectious diseases is a priority for the World
149              Preparing to rapidly respond to emerging infectious diseases is critical.
150               The introduction and spread of emerging infectious diseases is increasing in both preva
151 uring blood safety in the setting of rapidly emerging infectious diseases is needed.
152 n and spread or potential aerosol release of emerging infectious diseases, it will be critical to dev
153 (ANR-10-IAHU-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (A
154  double-stranded DNA (dsDNA) viruses causing emerging infectious diseases leading to extensive morbid
155            Chytridiomycosis is considered an emerging infectious disease linked to worldwide amphibia
156                           With the advent of emerging infectious diseases, many of which cannot be ad
157 outheastern Asia is a recognised hotspot for emerging infectious diseases, many of which have an anim
158 ake rapid assessments of the threat posed by emerging infectious diseases more generally.
159 s, vaccines, diagnostics, and treatments for emerging infectious diseases must be developed.
160 e Centers for Disease Control and Prevention Emerging Infectious Diseases Network, and infectious dis
161 dscape, we assess for the first time how two emerging infectious diseases (Nosema sp. and the Varroa-
162 onal Centers of Excellence in Biodefense and Emerging Infectious Diseases (NSRB) against BasE, an AAA
163      White-nose syndrome (WNS) is a seasonal emerging infectious disease of bats, which is caused by
164   Papillomatous digital dermatitis (PDD), an emerging infectious disease of cattle, is characterized
165                               When facing an emerging infectious disease of conservation concern, we
166 abesiosis has recently been recognized as an emerging infectious disease of dogs in North America.
167                Leptospirosis is zoonotic and emerging infectious disease of global importance.
168        Colonic spirochetosis (CS) is a newly emerging infectious disease of humans and animals caused
169                                              Emerging infectious diseases of wildlife can have severe
170                                              Emerging infectious diseases of zoonotic origin are shap
171                   Unique challenges posed by emerging infectious diseases often expose inadequacies i
172 ns is critical for mitigating the impacts of emerging infectious diseases on economically and ecologi
173 rstanding of the evolving social dynamics of emerging infectious diseases ought to help us to anticip
174                 Strategies for containing an emerging infectious disease outbreak must be nonpharmace
175 al surveillance systems in the context of an emerging infectious disease outbreak.
176         Stigma is widely observed during (re)emerging infectious disease outbreaks, contributing to p
177 come an essential technology for surveilling emerging infectious disease outbreaks.
178 o the clinical needs of patients affected by emerging infectious disease outbreaks.
179 need to monitor the changing consequences of emerging infectious diseases over time and the importanc
180  efforts to bring the current and any future emerging infectious disease pandemics to a close.
181 tion that has recently been identified as an emerging infectious disease particularly affecting an ab
182 een long used as a public health response to emerging infectious diseases, particularly at the onset
183 c liver abscess (PLA) is becoming a globally emerging infectious disease, population-based investigat
184 cale and rapidity of dissemination of recent emerging infectious diseases pose new challenges for vac
185                                              Emerging infectious diseases pose one of the greatest th
186                                              Emerging infectious diseases pose threats to wildlife po
187 vCJD was recently identified as one of three emerging infectious diseases posing the greatest immedia
188 f astrovirus (TAstV-2) from turkeys with the emerging infectious disease poult enteritis mortality sy
189 ogy pipeline, including immune responses and emerging infectious disease prediction, manufacturing an
190                                              Emerging infectious diseases present a formidable challe
191             An important but underrecognized emerging infectious disease problem in sub-Saharan Afric
192                                              Emerging infectious diseases rarely affect all members o
193                        Successful control of emerging infectious diseases requires accelerated develo
194                          These risks include emerging infectious diseases, resulting in part from inc
195 , which could increase biodiversity loss and emerging infectious disease risk.
196 estigations to address the public health and emerging infectious disease risks associated with bushme
197  can contribute to immune protection against emerging infectious disease risks such as antimicrobial-
198 artonellosis, a potentially life-threatening emerging infectious disease seen in the Andes Mountains
199                            Understanding how emerging infectious diseases spread within and between c
200                         Most emerging and re-emerging infectious diseases stem from viruses that natu
201                                              Emerging infectious diseases such as chytridiomycosis an
202 ng chronic diseases such as hypertension and emerging infectious diseases such as coronavirus disease
203 nd epidemiology and to control the spread of emerging infectious diseases such as COVID-19.
204 of smallpox and through natural outbreaks of emerging infectious diseases such as monkeypox.
205                                 Evidence for emerging infectious diseases such as Yersinia pestis add
206 d in the development of repurposed drugs for emerging infectious diseases such as, but not limited to
207 eneralist parasites are more likely to cause emerging infectious diseases, such biotic homogenisation
208 le diagnostics are inadequate and supplement emerging infectious disease surveillance systems to ensu
209                      Cryptosporidiosis is an emerging infectious disease that can be life-threatening
210                        Leptospirosis is a re-emerging infectious disease that presents a diagnostic e
211              Therefore, the adaptation of an emerging infectious disease, that exhibits superspreadin
212 ting and often dramatic reports of so-called emerging infectious diseases, the media have largely ign
213   As we start unravelling the full extent of emerging infectious diseases, there is an urgent need to
214 ected climate changes are thought to promote emerging infectious diseases, though to date, evidence l
215 lp public health officials plan for the next emerging infectious disease threat.The last 18 months ha
216  and large number of potential hosts of this emerging infectious disease threaten global amphibian di
217 me sets a new standard for rapid response to emerging infectious disease threats and clearly shows th
218                   Epidemics of WNV and other emerging infectious disease threats demand cost-efficien
219 ning for SARS research, as well as for other emerging infectious disease threats that are certain to
220 health preparedness against potential future emerging infectious disease threats.
221 recedented increase in the number of new and emerging infectious diseases throughout the world, with
222 recent paper published by Lowe and Romney in Emerging Infectious Diseases titled, Bed bugs as Vectors
223 unity patterns has implications ranging from emerging infectious disease to managing host microbiomes
224 blic data sets for the purposes of detecting emerging infectious diseases, to the discovery of novel
225   Consequently it supports the mitigation of emerging infectious diseases transmitted by Aedes aegypt
226 s an attempt to estimate risk factors for an emerging infectious disease using open data and to addre
227 ogenic change is contributing to the rise in emerging infectious diseases, which are significantly co
228 -US Collaborative Program on Emerging and Re-emerging Infectious Diseases, WHO, The Li Ka Shing Oxfor
229                          Leptospirosis is an emerging infectious disease whose pathology includes a h
230                                              Emerging infectious diseases will continue to threaten p
231 ns, suggesting an important pathway by which emerging infectious diseases will impact not only human
232      Severe acute respiratory syndrome is an emerging infectious disease with high morbidity and mort
233 y syndrome coronavirus (MERS-CoV) is a major emerging infectious disease with zoonotic potential and
234 erally considered rare, a number of recently emerging infectious diseases with load-dependent patholo
235  Immunology, and Clinical Characteristics of Emerging Infectious Diseases With Pandemic Potential (EP
236 ortem examination is especially important in emerging infectious diseases with potentially unknown in
237 lic has become keenly aware of the threat of emerging infectious diseases with the global spread of s
238                                              Emerging infectious diseases with zoonotic potential oft
239 ira spp., has recently been recognized as an emerging infectious disease worldwide.
240            Bats are important reservoirs for emerging infectious diseases, yet the mechanisms that al

 
Page Top